Estimation of losses of quality-adjusted life expectancy attributed to the combination of cognitive impairment and multimorbidity among Chinese adults aged 45 years and older

Abstract

Objectives This study aims to estimate the losses of quality-adjusted life expectancy (QALE) due to the joint effects of cognitive impairment and multimorbidity, and to further confirm additional losses attributable to this interaction among middle-aged and elderly Chinese people. Methods The National Cause of Death Monitoring Data were linked with the China Health and Retirement Longitudinal Study (CHARLS). A mapping and assignment method was used to estimate health utility values, which were further used to calculate QALE. Losses of QALE were measured by comparing the differences between subgroups. All the losses of QALE were displayed at two levels: the individual and population levels. Results At age 45, the individual-level and population-level losses of QALE attributed to the combination of cognitive impairment and multimorbidity were 7.61 (95% CI: 5.68, 9.57) years and 4.30 (95% CI: 3.43, 5.20) years, respectively. The losses for cognitive impairment alone were 3.10 (95% CI: 2.29, 3.95) years and 1.71 (95% CI: 1.32, 2.13) years at the two levels. Similarly, the losses for multimorbidity alone were 3.53 (95% CI: 2.53, 4.56) years and 1.91 (95% CI: 1.24, 2.63) years at the two levels. Additional losses due to the interaction of cognitive impairment and multimorbidity were indicated by the 0.98 years of the individual-level gap and 0.67 years of the population-level gap. Conclusion Among middle-aged and elderly Chinese people, cognitive impairment and multimorbidity resulted in substantial losses of QALE, and additional QALE losses were seen due to their interaction at both individual and population levels.

Multimorbidity, healthy lifestyle, and the risk of cognitive impairment in Chinese older adults: a longitudinal cohort study

“…It is estimated that approximately 15.6% of individuals aged 50 years or older have mild cognitive impairment [ 2 ], and more than 55 million people worldwide suffer from dementia currently, over 60% of whom live in low- and middle-income countries [ 3 ]. To address the significant disease burden caused by cognitive impairment [ 4 ], it is crucial to identify high-risk populations and modifiable risk factors associated with cognitive impairment [ 5 ].…”

Incidence of cognitive impairment after hypothetical interventions on depression, nighttime sleep duration, and leisure activity engagement among older Chinese adults: An application of the parametric g-formula

“…Cognitive impairment is an age-relevant intermediate stage of cognitive decline between the normal aging process and dementia, featuring cognition declines in memory, visuospatial ability, orientation, calculation, execution, and comprehension ( 1 , 2 ). Older adults with cognitive impairment tend to have a significantly higher risk of dementia, with a progression rate of 10%−30% per year, whereas those adults without cognitive impairment have a progression rate of 1%−2% annually ( 3 ).…”

Serum sTREM2: A Potential Biomarker for Mild Cognitive Impairment in Patients With Obstructive Sleep Apnea

“…It has been reported that OSA is an independent risk factor for the development of cognitive impairment manifested as a decline in attention, long-term memory, executive function, visuospatial ability, and information processing ( Leng et al, 2017 ; Zhu and Zhao, 2018 ). Cognitive impairment plays a role in reduced quality of life, increased healthcare costs, and increased mortality ( Li et al, 2021 ; Xiong et al, 2021 ). However, the assessment and longitudinal tracking of cognitive impairment in OSA is challenging.…”